Screener

Eligibility screening

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

Sponsored by Mabwell (Shanghai) Bioscience Co., Ltd.Study detailsClinicalTrials.gov

6 US sites in CA, CO, IL, MA +1

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.